Magnetic resonance imaging as a potential gold standard for infarct quantification

Journal of Electrocardiology

Volumn 41, Issue 6, 2008, Pages 614-620

  Carlsson, Marcus ^a,b   Arheden, Hakan ^b   Higgins, Charles B ^a   Saeed, Maythem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ECG; Heart; Infarct; MRI; Myocardium; Viability

Indexed keywords

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; REFERENCE STANDARDS;

EID: 55649113314     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2008.06.010     Document Type: Article

References (54)

1. Pennell D.J., Sechtem U.P., Higgins C.B., et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25 (2004) 1940
2. Engblom H., Arheden H., Foster J.E., and Martin T.N. Myocardial infarct quantification: is magnetic resonance imaging ready to serve as a gold standard for electrocardiography?. J Electrocardiol 40 (2007) 243
3. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 (2004) 1533
4. Saeed M., Wendland M.F., Masui T., and Higgins C.B. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 31 (1994) 31
5. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374
6. Baks T., Cademartiri F., Moelker A.D., et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. J Am Coll Cardiol 48 (2006) 144
7. Hsu L.Y., Natanzon A., Kellman P., Hirsch G.A., Aletras A.H., and Arai A.E. Quantitative myocardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 23 (2006) 298
8. Saeed M., Lee R.J., Weber O., et al. Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement. Eur Radiol 16 (2006) 827
9. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992
10. Arheden H., Saeed M., Higgins C.B., et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211 (1999) 698
11. Arheden H., Saeed M., Higgins C.B., et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215 (2000) 520
12. Kim R.J., Chen E.L., Lima J.A., and Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94 (1996) 3318
13. Higgins C.B., Siemers P.T., Schmidt W., and Newell J.D. Evaluation of myocardial ischemic damage of various ages by computerized transmission tomography. Time-dependent effects of contrast material. Circulation 60 (1979) 284
14. Petersen S.E., Mohrs O.K., Horstick G., et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 6 (2004) 541
15. Oshinski J.N., Yang Z., Jones J.R., Mata J.F., and French B.A. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 104 (2001) 2838
16. Wagner A., Mahrholdt H., Thomson L., et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol 47 (2006) 2027
17. Amado L.C., Gerber B.L., Gupta S.N., et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 44 (2004) 2383
18. Simonetti O., Kim R., Fieno D., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215
19. Heiberg E., Engblom H., Engvall J., Hedstrom E., Ugander M., and Arheden H. Semi-automatic quantification of myocardial infarction from delayed contrast enhanced magnetic resonance imaging. Scand Cardiovasc J 39 (2005) 267
20. Rosendahl L., Blomstrand P., Heiberg E., et al. Computer-assisted calculation of myocardial infarct size shortens the evaluation time of contrast-enhanced cardiac MRI. Clin Physiol Funct Imaging 28 (2008) 1
21. Heiberg E., Ugander M., Engblom H., et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 246 (2008) 581
22. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., and Lima J.A. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 (2002) 1083
23. Lund G.K., Stork A., Saeed M., et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 232 (2004) 49
24. Selvanayagam J.B., Kardos A., Francis J.M., et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110 (2004) 1535
25. Bondarenko O., Beek A.M., Hofman M.B., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7 (2005) 481
26. Kolipaka A., Chatzimavroudis G.P., White R.D., O'Donnell T.P., and Setser R.M. Segmentation of non-viable myocardium in delayed enhancement magnetic resonance images. Int J Cardiovasc Imaging 21 (2005) 303
27. Positano V., Pingitore A., Giorgetti A., et al. A fast and effective method to assess myocardial necrosis by means of contrast magnetic resonance imaging. J Cardiovasc Magn Reson 7 (2005) 487
28. Hsu L.Y., Ingkanisorn W.P., Kellman P., Aletras A.H., and Arai A.E. Quantitative myocardial infarction on delayed enhancement MRI. Part II: clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 23 (2006) 309
29. Schuijf J.D., Kaandorp T.A., Lamb H.J., et al. Quantification of myocardial infarct size and transmurality by contrast-enhanced magnetic resonance imaging in men. Am J Cardiol 94 (2004) 284
30. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539
31. Kim R.J., Albert T.S., Wible J.H., et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 117 (2008) 629
32. Fishbein M.C., Maclean D., and Maroko P.R. The histopathologic evolution of myocardial infarction. Chest 73 (1978) 843
33. Fieno D.S., Hillenbrand H.B., Rehwald W.G., et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 43 (2004) 2124
34. Saeed M., Saloner D., Martin A., et al. Adeno-associated viral vector-encoding vascular endothelial growth factor gene: effect on cardiovascular MR perfusion and infarct resorption measurements in swine. Radiology 243 (2007) 451
35. Lund G.K., Stork A., Muellerleile K., et al. Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging. Radiology 245 (2007) 95
36. Ripa R.S., Nilsson J.C., Wang Y., Sondergaard L., Jorgensen E., and Kastrup J. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. Am Heart J 154 (2007) 929
37. Abdel-Aty H., Zagrosek A., Schulz-Menger J., et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109 (2004) 2411
38. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496
39. Bogaert J., Kalantzi M., Rademakers F.E., Dymarkowski S., and Janssens S. Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 17 (2007) 2572
40. Sievers B., John B., Brandts B., Franken U., van Bracht M., and Trappe H.J. How reliable is electrocardiography in differentiating transmural from non-transmural myocardial infarction? A study with contrast magnetic resonance imaging as gold standard. Int J Cardiol 97 (2004) 417
41. Bayes de Luna A., Cino J.M., Pujadas S., et al. Concordance of electrocardiographic patterns and healed myocardial infarction location detected by cardiovascular magnetic resonance. Am J Cardiol 97 (2006) 443
42. Bayes de Luna A., Wagner G., Birnbaum Y., et al. A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circulation 114 (2006) 1755
43. Engblom H., Hedstrom E., Heiberg E., Wagner G.S., Pahlm O., and Arheden H. Size and transmural extent of first-time reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12-lead electrocardiogram. Am Heart J 150 (2005) 920
44. Engblom H., Wagner G.S., Setser R.M., et al. Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring. Am Heart J 146 (2003) 359
45. Moon J.C., De Arenaza D.P., Elkington A.G., et al. The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol 44 (2004) 554
46. Kaandorp T.A., Bax J.J., Lamb H.J., et al. Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram?. Am J Cardiol 95 (2005) 925
47. Bodi V., Sanchis J., Guillem M.S., et al. Analysis of the extension of Q-waves after infarction with body surface map: relationship with infarct size. Int J Cardiol 111 (2006) 399
48. Engblom H., Carlsson M.B., Hedstrom E., et al. The endocardial extent of reperfused first-time myocardial infarction is more predictive of pathologic Q waves than is infarct transmurality: a magnetic resonance imaging study. Clin Physiol Funct Imaging 27 (2007) 101
49. Martin T.N., Groenning B.A., Murray H.M., et al. ST-segment deviation analysis of the admission 12-lead electrocardiogram as an aid to early diagnosis of acute myocardial infarction with a cardiac magnetic resonance imaging gold standard. J Am Coll Cardiol 50 (2007) 1021
50. Tibrewala A.V., Asch F., Shah S., Fuisz A., and Lindsay Jr. J. Association of size of myocardial scar and persistence of ST-segment elevation after healing of anterior wall myocardial infarction. Am J Cardiol 99 (2007) 1106
51. Fernandes V.R., Wu K.C., Rosen B.D., et al. Enhanced infarct border zone function and altered mechanical activation predict inducibility of monomorphic ventricular tachycardia in patients with ischemic cardiomyopathy. Radiology 245 (2007) 712
52. Schmidt A., Azevedo C.F., Cheng A., et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115 (2007) 2006
53. Yan A.T., Shayne A.J., Brown K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006) 32
54. Ciaccio E.J., Ashikaga H., Kaba R.A., et al. Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping. Heart Rhythm 4 (2007) 1034